Clinical Trial

HDV Screening Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-17.
Trial Details
NCT Number NCT06889805
Lead Sponsor Grace Lai Hung Wong
Collaborators: Gilead Sciences
Conditions Hepatitis D Virus Infection
Enrollment 300 participants
Start Date 2025-02-15
Primary Completion 2028-08-17 (estimated)
Study Completion 2029-02-17 (estimated)
Updated on ClinicalTrials.gov 2025-03-24